Joel A. Yates

1.0k total citations
28 papers, 601 citations indexed

About

Joel A. Yates is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Joel A. Yates has authored 28 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Joel A. Yates's work include Cancer Cells and Metastasis (6 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Joel A. Yates is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Joel A. Yates collaborates with scholars based in United States, United Kingdom and Jordan. Joel A. Yates's co-authors include Sofía D. Merajver, Tushar Menon, Daniel A. Bochar, Liwei Bao, Andrew C. Little, Zhifen Wu, Megan Altemus, C. Ryan Oliver, Zhi Fen Wu and Matthew B. Soellner and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Joel A. Yates

27 papers receiving 595 citations

Peers

Joel A. Yates
Frederick Lang United States
Kathrine Woie Norway
Yunkai Yang China
Harvey E. Johnston United Kingdom
Yvonne W. Elderkamp Netherlands
Xiaoming Hou China
Vaibhao Janbandhu Australia
Zhuoqing Fang United States
Gina Lee United States
Songyan Han China
Frederick Lang United States
Joel A. Yates
Citations per year, relative to Joel A. Yates Joel A. Yates (= 1×) peers Frederick Lang

Countries citing papers authored by Joel A. Yates

Since Specialization
Citations

This map shows the geographic impact of Joel A. Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel A. Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel A. Yates more than expected).

Fields of papers citing papers by Joel A. Yates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel A. Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel A. Yates. The network helps show where Joel A. Yates may publish in the future.

Co-authorship network of co-authors of Joel A. Yates

This figure shows the co-authorship network connecting the top 25 collaborators of Joel A. Yates. A scholar is included among the top collaborators of Joel A. Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel A. Yates. Joel A. Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumaraswamy, Anbarasu, Rahul Mannan, Eva S. Rodansky, et al.. (2025). LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer. Neoplasia. 63. 101151–101151. 1 indexed citations
2.
Yates, Joel A., Megan Altemus, Liwei Bao, et al.. (2023). Blood–Brain Barrier Remodeling in an Organ‐on‐a‐Chip Device Showing Dkk1 to be a Regulator of Early Metastasis. SHILAP Revista de lepidopterología. 3(4). 9 indexed citations
3.
Morrissey, Colm, et al.. (2022). The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity. Frontiers in Endocrinology. 13. 926585–926585. 16 indexed citations
4.
Kumaraswamy, Anbarasu, Joel A. Yates, Shuang G. Zhao, et al.. (2021). Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer. European Urology. 80(1). 71–81. 42 indexed citations
5.
Ulintz, Peter, Joel A. Yates, Andrew C. Little, et al.. (2021). RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers. Frontiers in Oncology. 11. 712041–712041. 3 indexed citations
6.
Little, Andrew C., Ilya Kovalenko, Hanna S. Hong, et al.. (2020). High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions. Communications Biology. 3(1). 271–271. 51 indexed citations
7.
Coleman, Daniel J., David A. Sampson, Archana Sehrawat, et al.. (2020). Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4. Neoplasia. 22(6). 253–262. 24 indexed citations
8.
Little, Andrew C., Zhifen Wu, Liwei Bao, et al.. (2019). IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling. Frontiers in Oncology. 9. 456–456. 84 indexed citations
9.
Ulintz, Peter, Liwei Bao, John P. Lloyd, et al.. (2019). Molecular determinants of drug response in TNBC cell lines. Breast Cancer Research and Treatment. 179(2). 337–347. 8 indexed citations
10.
Oliver, C. Ryan, Megan Altemus, Xu Cheng, et al.. (2019). A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche. Lab on a Chip. 19(7). 1162–1173. 43 indexed citations
11.
Altemus, Megan, et al.. (2019). Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes. PLoS ONE. 14(9). e0220973–e0220973. 34 indexed citations
12.
Rosselli‐Murai, Luciana K., Joel A. Yates, Sei Yoshida, et al.. (2018). Loss of PTEN promotes formation of signaling-capable clathrin-coated pits. Journal of Cell Science. 131(8). 30 indexed citations
13.
Wynn, Michelle L., Joel A. Yates, Charles R. Evans, et al.. (2016). RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells. Journal of Biological Chemistry. 291(26). 13715–13729. 27 indexed citations
14.
Allen, Steven G., Yu‐Chih Chen, Julie Madden, et al.. (2016). Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling. Scientific Reports. 6(1). 39190–39190. 41 indexed citations
15.
Gerrett, Nicola, et al.. (2016). Ice slurry ingestion does not enhance self‐paced intermittent exercise in the heat. Scandinavian Journal of Medicine and Science in Sports. 27(11). 1202–1212. 25 indexed citations
16.
Yates, Joel A., Tushar Menon, Brandi Thompson, & Daniel A. Bochar. (2010). Regulation of HOXA2 gene expression by the ATP‐dependent chromatin remodeling enzyme CHD8. FEBS Letters. 584(4). 689–693. 34 indexed citations
17.
Yang, Li, Joel A. Yates, & Julian J.‐L. Chen. (2007). Identification and characterization of sea squirt telomerase reverse transcriptase. Gene. 400(1-2). 16–24. 8 indexed citations
18.
Yates, Joel A., et al.. (2004). Cln3 activates G1-specific transcription via phosphorylation of the SBF transcription bound repressor Whi5. UCL Discovery (University College London). 1 indexed citations
19.
Saliba, Elias K., et al.. (1988). Cutaneous leishmaniasis in Jordan: biochemical identification of human andPsammomys obesusisolates asLeishmania major. Annals of Tropical Medicine and Parasitology. 82(1). 21–25. 27 indexed citations
20.
Griffin, Jennifer, et al.. (1987). A comparison of angiographic and electrocardiographically gated computed tomographic measurements of left-ventricular function. British Journal of Radiology. 60(718). 969–974. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frederick Lang Breakdown of academic impact, for papers by Kathrine Woie Breakdown of academic impact, for papers by Yunkai Yang Breakdown of academic impact, for papers by Harvey E. Johnston Breakdown of academic impact, for papers by Yvonne W. Elderkamp Breakdown of academic impact, for papers by Xiaoming Hou Breakdown of academic impact, for papers by Vaibhao Janbandhu Breakdown of academic impact, for papers by Zhuoqing Fang Breakdown of academic impact, for papers by Gina Lee Breakdown of academic impact, for papers by Songyan Han
Rankless by CCL
2026